Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or the ‘Company’), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce the Company has filed a preliminary prospectus supplement (the ‘Supplement’) to its…
Feneck laid out and discussed five points investors should consider when evaluating a junior mining company in order of…
Metals Australia Ltd (ASX: MLS) (“Metals Australia” or “the Company”) is pleased to announce that drilling is set to…
Mining giant Rio Tinto (ASX:RIO,NYSE:RIO,LSE:RIO) is reportedly exploring the potential acquisition of lithium producer Arcadium Lithium (NYSE:ALTM,ASX:LTM) amid slumping…
Skyharbour Resources Ltd. (TSX-V: SYH ) (OTCQX: SYHBF ) (Frankfurt: SC1P ) (‘Skyharbour’ or the ‘Company’), partner company Medaro…
Artificial intelligence (AI) may be an emerging technology, but there are plenty of billion-dollar companies in this space. As…
The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) has traded at three-year highs in 2024 in response to looming interest rate cuts,…
White Cliff Minerals Limited (“the Company”) is delighted to announce the first batch of assay results from rock chip…
Boss Energy Limited (ASX: BOE|OTCQX: BQSSF) is pleased to announce that its 30 per cent-owned Alta Mesa ISR Uranium…